787 EFFECTS OF HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS OF BRIVANIB IN A PHASE I, OPEN-LABEL, MULTIDOSE STUDY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND OTHER SOLID TUMORS

Autor:	H.J. Lenz, E. Masson, J. Posey, V. Sankar, S. Shariq, Anthony B. El-Khoueiry, G. Kollia, T. Wood, Ian Walters, B. Fischer
Rok vydání:	2009
Předmět:	Oncology medicine.medical_specialty Hepatology business.industry Hepatic impairment medicine.disease Gastroenterology Pharmacokinetics Hepatocellular carcinoma Internal medicine medicine In patient Open label business
Zdroj:	Journal of Hepatology. 50:S288
ISSN:	0168-8278
DOI:	10.1016/s0168-8278(09)60789-3
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c30b5cd5cfc94fb47779ba0910bee3cc https://doi.org/10.1016/s0168-8278(09)60789-3 Zobrazit plný text záznamu Full Text from ScienceDirect